PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
NCT ID: NCT04057859
Last Updated: 2022-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
271 participants
OBSERVATIONAL
2013-11-30
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
NCT03070145
A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer
NCT00271687
Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial
NCT03658486
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
NCT03987217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and sign an approved Informed Consent Form (ICF)
* Diagnosed with locally advanced or metastatic prostate cancer
* Patient is treatment naive for ADT or has started ADT (3 or 4 month depot injection) AND has not received more than 1 treatment of 3 or 4 month ADT OR Patient is on intermittent therapy with an ADT agent and will be restarting ADT (3 or 4 month depot injection)
* ECOG (Eastern Cooperative Oncology Group) score of ≤ 2
* Willingness to track weekly physical activities with or without participating in a home based exercise program during the course of this study. The physical activities will be tracked with a weekly activity log or a NIKE+ Fuelband
Exclusion Criteria
* Has a survival expectancy of \< 2 years
* Has any other condition that, in the opinion of the treating physician, may affect the patient's health or outcome of the trial
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
CMX Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Casey, MD
Role: STUDY_DIRECTOR
CMX Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern Interior Medical Research Inc.
Kelowna, British Columbia, Canada
Silverado Research Inc.
Victoria, British Columbia, Canada
Barrie Urology Group
Barrie, Ontario, Canada
Euroscope Inc.
Barrie, Ontario, Canada
Dr. Gregory Leal
Belleville, Ontario, Canada
Jonathan Giddens Medical Professional Corp.
Brampton, Ontario, Canada
Brantford Urology Research
Brantford, Ontario, Canada
Kenneth Jansz Medical Professional Corp.
Burlington, Ontario, Canada
Michael L. Pianezza Medicine Professional Corp.
Greater Sudbury, Ontario, Canada
Northern Urology Centre
Greater Sudbury, Ontario, Canada
Stanley Flax Medical Professional Corp.
North York, Ontario, Canada
The Fe/Male Health Centres
Oakville, Ontario, Canada
The Fe/Male Health Centre
Oakville, Ontario, Canada
Kawartha Urology
Peterborough, Ontario, Canada
Urology Clinic
Scarborough Village, Ontario, Canada
Dr. Jonathan Chan Medical Professional Corp.
Toronto, Ontario, Canada
Umesh Jain Medicine Professional Corp.
Toronto, Ontario, Canada
Recherches Cliniques Theradev
Granby, Quebec, Canada
UroLaval
Laval, Quebec, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Ultra-Med Inc.
Pointe-Claire, Quebec, Canada
CHU de Quebec - L'hotel-dieu de Quebec
Québec, Quebec, Canada
Centre de Recherche en Urologie de Lanaudiere
Saint-Charles-Borromée, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMX-SC-2013-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.